Freedom to Heal Act of 2025

This bill would create a special federal registration that lets physicians directly give schedule I controlled substances to patients when those drugs qualify as investigational drugs under the federal Right to Try law. To apply, a physician would need an existing registration for schedule II–V drugs, proof of compliance with Right to Try, a supply agreement from the drug maker, state approval to provide the treatment, relevant training, and a description of the storage and treatment site. The Attorney General would have 45 days to either register the physician or start a process to deny the application. Physicians could only hold the drug amounts listed in their application or in a later request for more, which would be approved after 30 days unless challenged. The Attorney General would have to issue an interim rule within 240 days and a final rule within 2 years after that.

Full text and official record on Congress.gov

Sponsors

• Cory A. Booker Democrat sponsor
• 2 cosponsors